GLP-1 agonists are medications designed to replicate the effects of a natural hormone in the body called glucagon-like peptide-1
It is metabolically active, supporting glucose disposal, stabilising blood sugar after meals, and maintaining insulin sensitivity
This comprehensive analysis addresses these consumer questions by examining the current landscape of GLP-1 weight loss medications, comparing regulatory frameworks, pricing structures, format options, and access pathways
4.6.2 Retinal disease Diabetic retinopathy (DR) is the most prevalent microvascular complication of diabetes and the leading cause of preventable blindness among working-age individuals (81)
Retatrutide is not available on NHS prescription
Heres what we unpack: Why most GLP-1 strategies miss the mark What happens when employees stop taking them The root causes GLP-1s dont touch like systemic chronic inflammation How behavior change unlocks lasting health - and real savings GLP-1s treat symptoms